Through the 90-day period concluding December 12, 2025, KalVista Pharmaceuticals's top three insider stakeholders include TenPercentOwner Healthcare Capital Partners Iii, L.P. Venrock (5.30Mn shares), Chief Executive Officer Benjamin L Palleiko (424.52K shares), Chief Development Officer Christopher Yea (223.51K shares).
| Holder | Position | Shares | Report Date |
|---|---|---|---|
| Healthcare Capital Partners Iii, L.P. Venrock | 5,303,985 | 11 Apr, 2025 | |
| Benjamin L Palleiko | Chief Executive Officer | 424,520 | 09 Dec, 2025 |
| Christopher Yea | Chief Development Officer | 223,508 | 26 Nov, 2025 |
| Thomas Andrew Crockett | CEO | 211,203 | 21 Feb, 2024 |
| Paul K. Audhya | Chief Medical Officer | 131,831 | 26 Nov, 2025 |
| Edward P. Feener | Chief Scientific Officer | 72,858 | 21 May, 2024 |
| Nicole Sweeny | Chief Commercial Officer | 39,728 | 04 Dec, 2025 |
| Brian Piekos | Chief Financial Officer | 10,529 | 26 Nov, 2025 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 06 Dec, 2025 | Benjamin L Palleiko | Common Stock | A | 15,625 | - | 431,814 | D | M |
| 08 Dec, 2025 | Benjamin L Palleiko | Common Stock | D | 7,294 | $16.51 | 424,520 | D | S |
| 21 Nov, 2025 | Paul K. Audhya | Common Stock | A | 6,250 | - | 132,127 | D | M |
| 21 Nov, 2025 | Brian Piekos | Common Stock | A | 15,000 | - | 15,000 | D | M |
| 21 Nov, 2025 | Benjamin L Palleiko | Common Stock | A | 23,250 | - | 427,129 | D | M |
| 21 Nov, 2025 | Christopher Yea | Common Stock | A | 3,750 | - | 224,714 | D | M |
| 21 Nov, 2025 | Nicole Sweeny | Common Stock | A | 6,250 | - | 38,541 | D | M |
| 22 Nov, 2025 | Christopher Yea | Common Stock | A | 3,125 | - | 227,839 | D | M |
| 22 Nov, 2025 | Paul K. Audhya | Common Stock | A | 5,000 | - | 137,127 | D | M |
| 24 Nov, 2025 | Brian Piekos | Common Stock | D | 4,471 | $13.45 | 10,529 | D | S |
| 22 Nov, 2025 | Nicole Sweeny | Common Stock | A | 5,000 | - | 43,541 | D | M |
| 24 Nov, 2025 | Benjamin L Palleiko | Common Stock | D | 10,940 | $13.45 | 416,189 | D | S |
| 24 Nov, 2025 | Paul K. Audhya | Common Stock | D | 5,296 | $13.45 | 131,831 | D | S |
| 24 Nov, 2025 | Nicole Sweeny | Common Stock | D | 3,813 | $13.45 | 39,728 | D | S |
| 24 Nov, 2025 | Christopher Yea | Common Stock | D | 4,331 | $13.45 | 223,508 | D | S |
| 20 Nov, 2025 | Christopher Yea | Common Stock | A | 87,390 | $0.00 | 220,964 | D | M |
| 17 Nov, 2025 | Christopher Yea | Common Stock | A | 4,205 | - | 136,257 | D | M |
| 17 Nov, 2025 | Benjamin L Palleiko | Common Stock | A | 9,364 | - | 408,345 | D | M |
| 17 Nov, 2025 | Paul K. Audhya | Common Stock | A | 6,447 | - | 128,952 | D | M |
| 18 Nov, 2025 | Benjamin L Palleiko | Common Stock | D | 4,466 | $14.48 | 403,879 | D | S |